Education
About Us
Working with TipRanks
Follow Us
Apimeds Pharmaceuticals US, Inc. (APUS)
:APUS
Apimeds Pharmaceuticals US, Inc. (APUS) Ownership Overview
64.31% Insiders
0.51% Mutual Funds
2.18% Other Institutional Investors
0.28% ETFs
32.72% Public Companies and
Individual Investors
The ownership structure of Apimeds Pharmaceuticals US, Inc. (APUS) stock is a mix of institutional, retail, and individual investors. Approximately 2.97% of the company’s stock is owned by Institutional Investors, 64.31% is owned by Insiders, and 32.72% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
May 15, 2025 | xxxxxxxxxxxxx | $50359 | |
May 14, 2025 | xxxxxxxxxxxxx | $772598 | |
May 14, 2025 | xxxxxxxxxxxxx | $2000000 | |
May 14, 2025 | xxxxxxxxxxxxx | $56715 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,416,365 | Insider | 51.02% | 9,047,075 | |
| 750,000 | Insider | 5.96% | 1,057,500 | |
| 643,885 | Insider | 5.12% | 907,878 | |
| 277,500 | Insider | 2.21% | 391,275 | |
| 34,953 | Institution | 0.28% | 49,284 | |
| 34,953 | Institution | 0.28% | 49,284 | |
| 29,541 | Institution | 0.23% | 41,653 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 34,953 | Institution | 0.28% | 49,284 | |
| 29,541 | Institution | 0.23% | 41,653 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 34,953 | Institution | 0.28% | 64,663 |
FAQ
Who Owns Apimeds Pharmaceuticals US, Inc. (APUS)?
According to the latest TipRanks data, approximately 2.18% of the company's stock is held by institutional investors, 64.31% is held by insiders, and 32.72% is held by retail investors.
What percentage of Apimeds Pharmaceuticals US, Inc. (APUS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 2.18% of Apimeds Pharmaceuticals US, Inc. (APUS) stock is held by institutional investors.
What percentage of Apimeds Pharmaceuticals US, Inc. (APUS) stock is held by retail investors?
According to the latest TipRanks data, approximately 32.72% of Apimeds Pharmaceuticals US, Inc. (APUS) stock is held by retail investors.
Who owns the most shares of Apimeds Pharmaceuticals US, Inc. (APUS)?
Inscobee Inc. owns the most shares of Apimeds Pharmaceuticals US, Inc. (APUS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.